Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
First line treatment of chronic phase chronic myeloid leukaemia patients with the generic formulations of imatinib mesylate. [electronic resource] by
- Eskazan, Ahmet Emre
- Ayer, Mesut
- Kantarcioglu, Bulent
- Arica, Deniz
- Demirel, Naciye
- Aydin, Demet
- Yalniz, Fevzi Firat
- Elverdi, Tugrul
- Salihoglu, Ayse
- Ar, Muhlis Cem
- Ongoren Aydin, Seniz
- Baslar, Zafer
- Aydin, Yildiz
- Tuzuner, Nukhet
- Ozbek, Ugur
- Soysal, Teoman
Producer: 20141118
In:
British journal of haematology vol. 167
Availability: No items available.
|
|
10.
|
Outcomes of Chronic Myeloid Leukemia Patients With Early Molecular Response at 3 and 6 Months: A Comparative Analysis of Generic Imatinib and Glivec. [electronic resource] by
- Eskazan, Ahmet Emre
- Sadri, Sevil
- Keskin, Dilek
- Ayer, Mesut
- Kantarcioglu, Bulent
- Demirel, Naciye
- Aydin, Demet
- Aydinli, Fuat
- Yokus, Osman
- Ozunal, Isil Erdogan
- Berk, Selin
- Yalniz, Fevzi Firat
- Elverdi, Tugrul
- Salihoglu, Ayse
- Ar, Muhlis Cem
- Ongoren, Seniz
- Baslar, Zafer
- Aydin, Yildiz
- Tuzuner, Nukhet
- Ozbek, Ugur
- Soysal, Teoman
Producer: 20180709
In:
Clinical lymphoma, myeloma & leukemia vol. 17
Availability: No items available.
|